For years, the headlines in European healthcare technology have belonged to the mega deals: the billion euro platform buyouts, the unicorn funding rounds, the flagship acquisitions by global strategics. But beneath that headline layer sits a much larger, much less visible engine room, the lower to middle market (LMM). These are the founder led and family owned HealthTech and MedTech businesses generating roughly €5 million to €50 million in annual revenue, with enterprise val